Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version
Tamio Teramoto,Jun Sasaki,Shun Ishibashi,Sadatoshi Birou,Hiroyuki Daida,Seitaro Dohi,Genshi Egusa,Takafumi Hiro,Kazuhiko Hirobe,Mami Iida,Shinji Kihara,Makoto Kinoshita,Chizuko Maruyama,Takao Ohta,Tomonori Okamura,Shizuya Yamashita,Masayuki Yokode,Koutaro Yokote +17 more
About:
This article is published in Journal of Atherosclerosis and Thrombosis.The article was published on 2013-01-01 and is currently open access. It has received 437 citations till now.read more
Citations
More filters
Journal ArticleDOI
Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR
Yong Hoon Kim,Ae Young Her,Myung Ho Jeong,Byeong Keuk Kim,Sung Jin Hong,Dong Ho Shin,Jung Sun Kim,Young Guk Ko,Donghoon Choi,Myeong Ki Hong,Yangsoo Jang +10 more
TL;DR: The AMI patients with dyslipidemia receiving ZES, EES, or BES after PCI showed comparable safety and efficacy during 2-year follow-up periods, therefore, DP-DES or BP-DES is equally acceptable in Dyslipidemic AMi patients during PCI.
Journal ArticleDOI
Current familial hypercholesterolemia diagnostic criteria underdiagnose APOB mutations: Lessons from the Amish community
TL;DR: Wide scale genetic population sampling or testing of patients with ‘‘general’’ hypercholesterolemia has shown defects in APOB to be frequent in certain ethnic populations and appears at variable LDL-C levels often lower than those accepted as phenotypically diagnostic of FH, an effect accentuated in younger patients.
Journal ArticleDOI
Economic Evaluation of Pravastatin for Primary Prevention of Coronary Artery Disease Based on Risk Prediction from JALS-ECC in Japan
TL;DR: Using risk prediction for CAD based on a Japanese cohort with no history of cardiovascular events, the cost-effectiveness of pravastatin for primary prevention of CAD may not be cost-effective in populations at both low and high cardiac risk.
Journal ArticleDOI
Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design
Junya Ako,Kiyoshi Hibi,Ken Kozuma,Katsumi Miyauchi,Yoshihiro Morino,Toshiro Shinke,Kenichi Tsujita,Kiyoko Uno,Yumiko Kawabata,Takafumi Hiro +9 more
TL;DR: In insights into the effect of alirocumab on coronary atherosclerotic plaque volume in patients with a recent acute coronary syndrome and hypercholesterolemia while on stable statin therapy are provided.
Journal ArticleDOI
Associations of sleep quality, sleep apnea and autonomic function with insulin secretion and sensitivity: HSCAA study.
Miki Kakutani-Hatayama,Manabu Kadoya,Akiko Morimoto,Akio Miyoshi,Kae Kosaka-Hamamoto,Yoshiki Kusunoki,Takuhito Shoji,Hidenori Koyama +7 more
TL;DR: Poor sleep quality is an independent predictor of pancreatic β-cell function, which could be involved in occurrence of type 2 diabetes.
References
More filters
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
William C. Taylor,Nigel Unwin +1 more
Journal ArticleDOI
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
Daniel H. O'Leary,Joseph F. Polak,Richard A. Kronmal,Teri A. Manolio,Gregory L. Burke,Sidney K. Wolfson +5 more
TL;DR: Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of cardiovascular disease.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
TL;DR: These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians but also specialists from lipid clinics or metabolic units who are dealing with dyslipIDAemias that are more difficult to classify and treat.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias
Alberico L. Catapano,Željko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
Journal ArticleDOI
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study
W M Verschuren,David R. Jacobs,Bennie P. M. Bloemberg,Daan Kromhout,Alessandro Menotti,Christ Aravanis,Henry Blackburn,Ratko Buzina,Anastasios Dontas,Flaminio Fidanza +9 more
TL;DR: The large difference in absolute CHD mortality rates at a given cholesterol level, however, indicates that other factors, such as diet, that are typical for cultures with a low CHD risk are also important with respect to primary prevention.
Related Papers (5)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more